Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hood

Showing results (581-590 of 610) with videos related to

Pageof 61
Sort By:
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Journal of Proteome Research|March 10, 2015
Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patientsNicholas W Bateman, Elizabeth Jaworski, Wei Ao, et al.
Translational Psychiatry|July 12, 2017
Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veteransR Hammamieh, N Chakraborty, A Gautam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.
Gynecologic Oncology|August 28, 2023
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.
Gynecologic Oncology|April 5, 2011
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammationG Larry Maxwell, Brian L Hood, Roger Day, et al.
Cancer|June 28, 2017
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsNicholas W Bateman, Elizabeth A Dubil, Guisong Wang, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Journal of Translational Medicine|December 17, 2022
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivorsKwong-Kwok Wong, Nicholas W Bateman, Chun Wai Ng, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Pageof 61

Showing results (581-590 of 610) with videos related to

Sort By:
Pageof 61
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Journal of Proteome Research|March 10, 2015
Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patientsNicholas W Bateman, Elizabeth Jaworski, Wei Ao, et al.
Translational Psychiatry|July 12, 2017
Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veteransR Hammamieh, N Chakraborty, A Gautam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.
Gynecologic Oncology|August 28, 2023
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.
Gynecologic Oncology|April 5, 2011
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammationG Larry Maxwell, Brian L Hood, Roger Day, et al.
Cancer|June 28, 2017
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsNicholas W Bateman, Elizabeth A Dubil, Guisong Wang, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Journal of Translational Medicine|December 17, 2022
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivorsKwong-Kwok Wong, Nicholas W Bateman, Chun Wai Ng, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Pageof 61